| Pharmaceutical Information |
| Drug Name |
Cysteine hydrochloride |
| Drug ID |
BADD_D00559 |
| Description |
A thiol-containing non-essential amino acid that is oxidized to form cystine. |
| Indications and Usage |
For the prevention of liver damage and kidney damage associated with overdoses of acetaminophen |
| Marketing Status |
approved; nutraceutical |
| ATC Code |
Not Available |
| DrugBank ID |
DB00151
|
| KEGG ID |
D02326
|
| MeSH ID |
D003545
|
| PubChem ID |
25150
|
| TTD Drug ID |
D0P0QK
|
| NDC Product Code |
51754-1007; 0338-9645 |
| UNII |
ZT934N0X4W
|
| Synonyms |
Cysteine | L-Cysteine | L Cysteine | Half-Cystine | Half Cystine | Zinc Cysteinate | Cysteine Hydrochloride |
|
| Chemical Information |
| Molecular Formula |
C3H8ClNO2S |
| CAS Registry Number |
10318-18-0 |
| SMILES |
C(C(C(=O)O)N)S.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Erythema | 23.03.06.001 | - | - | Not Available | | Feeling hot | 08.01.09.009 | - | - | Not Available | | Flushing | 23.06.05.003; 08.01.03.025; 24.03.01.002 | - | - | | | Nausea | 07.01.07.001 | - | - | | | Pyrexia | 08.05.02.003 | - | - | | | Thrombosis | 24.01.01.006 | - | - | Not Available | | Infusion site phlebitis | 24.12.03.002; 12.07.05.004; 08.02.05.003 | - | - | Not Available |
|
The 1th Page
1
Total 1 Pages
|
|
